Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC) (Molecular Imaging and Biology, (2014), 16, 3, (431-440), 10.1007/s11307-013-0699-7)

Lanell M. Peterson, Brenda F. Kurland, Erin K. Schubert, Jeanne M. Link, V. K. Gadi, Jennifer M. Specht, Janet F. Eary, Peggy Porter, Lalitha K. Shankar, David A. Mankoff, Hannah M. Linden

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC) (Molecular Imaging and Biology, (2014), 16, 3, (431-440), 10.1007/s11307-013-0699-7)'. Together they form a unique fingerprint.

Medicine & Life Sciences